Skip to main content

Health Alerts

Your unified view of current, active outbreak investigations, elevated disease activity, and food and drug recalls -- reported directly by CDC, FDA, and USDA. Not CDC NORS, which is a historical archive compiled well after an investigation closes (see Data Explorer for the full historical record).

Download matching alerts as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Date range
Sort
Clear filters

Showing 61–80 of 224 alerts

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Carton: 55154-3558-0; NDC Blister: 0904-6949-61

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6956-61

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6955-61

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 112 mcg (0.0112 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6954-61

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6952-61

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6951-61

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6950-61

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6949-61

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

BD ChloraPrep Clear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol), 60 x 1 mL applicators/carton, 0.03fl oz (1 mL) each, STERILE SOLUTION, CareFusion 123, LLC, El Paso, TX, subsidiary of Beckton, Dickson and Co. NDC 54365-400-31

Recall initiated
July 9, 2026
Reported by FDA
July 22, 2026

View Details

Drug Recall 2026 record Source: FDA

Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC., Parsnippany, NJ 07054. NDC: 67877-500-30

Recall initiated
July 8, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30.

Recall initiated
July 6, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary, NC 27518, by Fresenius Kabi, Graz, Austria, NDC 10122-611-10.

Recall initiated
July 6, 2026
Reported by FDA
July 22, 2026

View Details

Food Recall 2026 record Source: FDA

Frutas y Hortalizas del Sur S.A.

Recall initiated
July 3, 2026
Reported by FDA
July 22, 2026

View Details

Drug Recall 2026 record Source: FDA

Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00.

Recall initiated
July 2, 2026
Reported by FDA
August 5, 2026

View Details

Drug Recall 2026 record Source: FDA

Glutathione (MDV), 200 mg/mL, 30 mL vial, each mL contains Glutathione 200 mg, Ascorbic Acid 20 mg, Benzyl Alcohol 1.5%, Na Hydroxide (Ph Adjust) in sterile water for injection, VMC.

Recall initiated
July 1, 2026
Reported by FDA
August 19, 2026

View Details

Data last updated:

Investigations and recalls may be ongoing; status, case counts, and guidance are updated by the source agency as events continue. Read the full medical disclaimer.

Explore more